YURAK-QON TOMIR TIZIMI EKSTRAGENITAL PATOLOGIYALARI BOʻLGAN HOMILADOR AYOLLARDA PREEKLAMPSIYA RIVOJLANISHINI ERTA PROGNOZLASH VA PROFILAKTIKA QILISHNING ZAMONAVIY KLINIK-BIOKIMYOVIY MEZONLARI

Authors

  • Muminova Madina Salim qizi Samarkand Davlat Tibbiyot Universiteti ordinator akusher ginekolog
  • Safarova Gulrux Tolibjon qizi Samarkand Davlat Tibbiyot Universiteti ordinator akusher ginekolog

Keywords:

preeklampsiya, ekstragenital patologiya, yurak-qon tomir tizimi, endotelial disfunksiya, sFlt-1/PlGF nisbati, erta prognozlash, profilaktika.

Abstract

Ushbu maqolada yurak-qon tomir tizimi (YQTT) ekstragenital patologiyalari boʻlgan homilador ayollarda preeklampsiya (PE) rivojlanishini erta prognozlash va profilaktika qilishning zamonaviy klinik-biokimyoviy mezonlari yoritilgan. YQTT kasalliklari fonida preeklampsiya kechishi ona va bola oʻlimi hamda perinatal asoratlar xavfini sezilarli darajada oshiradi. Tadqiqotda endotelial disfunksiya, angiogen disbalans (sFlt-1/PlGF nisbati) va metabolik oʻzgarishlarning diagnostik ahamiyati tahlil qilingan. Klinik-biokimyoviy monitoring yordamida patologiyani birinchi va ikkinchi trimestrda erta aniqlash hamda uning patogenetik profilaktikasi chora-tadbirlari asoslab berilgan.

References

Khan, K.S., Wojdyla, D., Say, L., Gülmezoglu, A.M., Van Look, P.F. WHO analysis of causes of maternal death: a systematic review. The Lancet, 2006. Vol. 367, pp. 1066-1074.

Magee, L.A., Pels, A., Helewa, M., Rey, E., von Dadelszen, P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension, 2014. Vol. 4(2), pp. 105-145.

Redman, C.W., Sargent, I.L. Latest advances in understanding preeclampsia. Science, 2005. Vol. 308(5728), pp. 1592-1594.

Cnossen, J.S., Morris, R.K., ter Riet, G., Mol, B.W., van der Post, J.A. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia. CMAJ, 2008. Vol. 178(6), pp. 701-711.

Powe, C.E., Levine, R.J., Karumanchi, S.A. Preeclampsia, a disease of the maternal endothelium. Circulation, 2011. Vol. 123(24), pp. 2856-2869.

Levine, R.J., Maynard, S.E., Qian, C., et al. Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine, 2004. Vol. 350(7), pp. 672-683.

Zeisler, H., Llurba, E., Chantraine, F., et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. New England Journal of Medicine, 2016. Vol. 374(1), pp. 13-22.

Roberts, J.M., Cooper, D.W. Pathogenesis and genetics of pre-eclampsia. The Lancet, 2001. Vol. 357(9249), pp. 53-56.

Rolnik, D.L., Wright, D., Poon, L.C., et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. New England Journal of Medicine, 2017. Vol. 377(7), pp. 613-622.

Regitz-Zagrosek, V., Roos-Hesselink, J.W., Bauersachs, J., et al. ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal, 2018. Vol. 39(34), pp. 3165-3224.

Duley, L., Gülmezoglu, A.M., Henderson-Smart, D.J., Chou, D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews, 2010. Iss. 11, pp. 1-45.

Brown, M.A., Magee, L.A., Kenny, L.C., et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension, 2018. Vol. 72(1), pp. 24-43.

Downloads

Published

2026-06-09

How to Cite

Muminova Madina Salim qizi, & Safarova Gulrux Tolibjon qizi. (2026). YURAK-QON TOMIR TIZIMI EKSTRAGENITAL PATOLOGIYALARI BOʻLGAN HOMILADOR AYOLLARDA PREEKLAMPSIYA RIVOJLANISHINI ERTA PROGNOZLASH VA PROFILAKTIKA QILISHNING ZAMONAVIY KLINIK-BIOKIMYOVIY MEZONLARI. IQRO , 22(01), 1007–1011. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/8173